• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载环孢素A的聚乳酸-聚乙二醇聚乙二醇微米和纳米颗粒的制备与表征。与传统聚乳酸颗粒载体的比较。

Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.

作者信息

Gref R, Quellec P, Sanchez A, Calvo P, Dellacherie E, Alonso M J

机构信息

School of Pharmacy, University of Paris Sud, UMR CNRS 8612, Châtenay Malabry, France.

出版信息

Eur J Pharm Biopharm. 2001 Mar;51(2):111-8. doi: 10.1016/s0939-6411(00)00143-0.

DOI:10.1016/s0939-6411(00)00143-0
PMID:11226817
Abstract

Cyclosporin A (CyA) loaded poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) micro- and nanoparticles have been developed using an emulsion-solvent evaporation method. Physico-chemical properties, peptide loading content and in vitro release profiles of these novel CyA carriers were compared with those corresponding to conventional PLA micro- and nanoparticles. Results obtained confirm the previously described disposition of PEG chains on the surface of the PLA-PEG formulations. In addition, they revealed the presence of CyA molecules on the surface of both PLA and PLA-PEG systems. Further determination of the surface chemical composition by electron spectroscopy for chemical analysis (ESCA) allowed us to quantify the amount of CyA in the nanospheres' top layers, this amount being higher for nanoparticles than for microparticles, and higher for the PLA systems than for those based on PLA-PEG. In vitro release experiments revealed that PLA-PEG particles provided a more adequate control of CyA release than conventional PLA micro- and nanoparticles. Physico-chemical characterization of the systems during the release studies showed that the developed PLA and PLA-PEG micro- and nanoparticles were not degraded, which suggest a diffusion-mediated release mechanism. Furthermore, we have hypothesized that the hydrophilic outer shell of PEG provides a stationary layer for the diffusion of CyA.

摘要

采用乳液-溶剂蒸发法制备了负载环孢素A(CyA)的聚乳酸-聚乙二醇(PLA-PEG)微米和纳米颗粒。将这些新型CyA载体的物理化学性质、肽负载量和体外释放曲线与相应的传统PLA微米和纳米颗粒进行了比较。所得结果证实了先前所述的PEG链在PLA-PEG制剂表面的分布情况。此外,结果还显示在PLA和PLA-PEG体系的表面均存在CyA分子。通过化学分析电子能谱(ESCA)进一步测定表面化学成分,使我们能够量化纳米球顶层中CyA的含量,纳米颗粒中的该含量高于微米颗粒,且PLA体系中的含量高于基于PLA-PEG的体系。体外释放实验表明,与传统的PLA微米和纳米颗粒相比,PLA-PEG颗粒对CyA释放的控制更为理想。释放研究过程中对体系的物理化学表征表明,所制备的PLA和PLA-PEG微米和纳米颗粒未发生降解,这表明其释放机制为扩散介导。此外,我们推测PEG的亲水性外壳为CyA的扩散提供了一个固定层。

相似文献

1
Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.负载环孢素A的聚乳酸-聚乙二醇聚乙二醇微米和纳米颗粒的制备与表征。与传统聚乳酸颗粒载体的比较。
Eur J Pharm Biopharm. 2001 Mar;51(2):111-8. doi: 10.1016/s0939-6411(00)00143-0.
2
Cyclosporine A Loaded Electrospun Poly(D,L-Lactic Acid)/Poly(Ethylene Glycol) Nanofibers: Drug Carriers Utilizable in Local Immunosuppression.载环孢素A的电纺聚(D,L-乳酸)/聚乙二醇纳米纤维:可用于局部免疫抑制的药物载体
Pharm Res. 2017 Jul;34(7):1391-1401. doi: 10.1007/s11095-017-2155-x. Epub 2017 Apr 12.
3
Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres.脂肪酸酯对聚(L-乳酸)微球中环孢素A释放速率的修饰及微球的体内评价
J Control Release. 1999 Mar 29;58(2):133-41. doi: 10.1016/s0168-3659(98)00146-1.
4
5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.载 5-氟尿嘧啶的 PLA/PLGA-PEG-PPG-PEG 嵌段共聚物纳米粒的制备、体外评价及细胞培养研究。
Drug Dev Ind Pharm. 2014 Apr;40(4):560-7. doi: 10.3109/03639045.2013.775581. Epub 2013 Apr 18.
5
Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.用于紫杉醇控释的聚乳酸-聚乙二醇-聚乳酸(PLA-PEG-PLA)微球的制备与表征
Biomaterials. 2003 Dec;24(27):5037-44. doi: 10.1016/s0142-9612(03)00419-8.
6
Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.聚乳酸-聚乙二醇纳米颗粒作为递送质粒DNA的新型载体
J Control Release. 2001 Jul 10;75(1-2):211-24. doi: 10.1016/s0168-3659(01)00397-2.
7
Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.载多西紫杉醇聚乳酸-聚乙二醇纳米粒的制备、表征及体外评价。
J Biomed Nanotechnol. 2010 Dec;6(6):675-82. doi: 10.1166/jbn.2010.1160.
8
Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.载罗丹明的聚乙二醇-聚乳酸纳米粒(NPs)的表征:聚乙二醇接枝密度的影响。
Int J Pharm. 2011 Jun 15;411(1-2):178-87. doi: 10.1016/j.ijpharm.2011.02.039. Epub 2011 Mar 31.
9
Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer.高压均质机制备的载环孢素A微米和纳米颗粒释放速率的影响因素研究。
J Control Release. 2002 Dec 5;84(3):115-23. doi: 10.1016/s0168-3659(02)00239-0.
10
Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.通过气体抗溶剂技术制备负载胰岛素的聚乙二醇/聚左旋乳酸(PEG/PLA)纳米颗粒。
J Pharm Sci. 2001 Oct;90(10):1628-36. doi: 10.1002/jps.1113.

引用本文的文献

1
Cryo-electron tomography investigation of serum albumin-camouflaged tobacco mosaic virus nanoparticles.血清白蛋白包裹的烟草花叶病毒纳米颗粒的冷冻电子断层扫描研究。
Nanoscale. 2017 Mar 9;9(10):3408-3415. doi: 10.1039/c6nr06948g.
2
Novel formulations for antimicrobial peptides.抗菌肽的新型制剂
Int J Mol Sci. 2014 Oct 9;15(10):18040-83. doi: 10.3390/ijms151018040.
3
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.工程纳米材料的免疫抑制和抗炎特性。
Br J Pharmacol. 2014 Sep;171(17):3988-4000. doi: 10.1111/bph.12722. Epub 2014 Jul 2.
4
Co-delivery of Sildenafil (Viagra(®)) and Crizotinib for synergistic and improved anti-tumoral therapy.西地那非(伟哥®)与克唑替尼联合给药用于协同增效及改善抗肿瘤治疗。
Pharm Res. 2014 Sep;31(9):2516-28. doi: 10.1007/s11095-014-1347-x. Epub 2014 Mar 13.
5
Novel poly(L-lactide-co-ε-caprolactone) matrices obtained with the use of Zr[Acac]₄ as nontoxic initiator for long-term release of immunosuppressive drugs.新型聚(L-丙交酯-co-ε-己内酯)基质,使用 Zr[Acac]₄ 作为无毒引发剂,用于长期释放免疫抑制剂药物。
Biomed Res Int. 2013;2013:607351. doi: 10.1155/2013/607351. Epub 2013 Oct 28.
6
Emulsification/internal gelation as a method for preparation of diclofenac sodium-sodium alginate microparticles.乳化/内凝胶法制备双氯芬酸钠-海藻酸钠微球。
Saudi Pharm J. 2013 Jan;21(1):61-9. doi: 10.1016/j.jsps.2011.08.004. Epub 2011 Sep 8.
7
Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres.用于制备载蛋白聚乳酸-羟基乙酸共聚物纳米球的两步纳米沉淀法。
Results Pharma Sci. 2012;2:79-85. doi: 10.1016/j.rinphs.2012.11.001.
8
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A.包封环孢素A的尺寸可控聚乙二醇-聚乳酸纳米颗粒的免疫抑制活性
J Transplant. 2012;2012:896141. doi: 10.1155/2012/896141. Epub 2012 Mar 29.
9
Construction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity.紫杉醇载药聚(2-羟乙基甲基丙烯酸酯)-g-聚(乳酸)-1,2-二月桂酰基-sn-甘油-3-磷酸乙醇胺共聚物纳米粒给药系统的构建及抗癌活性评价。
Int J Nanomedicine. 2012;7:1313-28. doi: 10.2147/IJN.S29371. Epub 2012 Mar 7.
10
Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers.适合包封和递送恩度的载体:载恩度的微粒载体的比较。
Int J Nanomedicine. 2011;6:1535-41. doi: 10.2147/IJN.S21881. Epub 2011 Jul 22.